Myocardial Stress Perfusion Imaging With Dual Source CT

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00853671
Collaborator
Astellas Pharma Inc (Industry)
50
1
1
24
2.1

Study Details

Study Description

Brief Summary

The investigators propose a novel technique using dual source multidetector computed tomography (DSCT) where information on both coronary anatomy and myocardial perfusion is obtained in a single scan. The investigators hypothesize that a coronary CTA protocol can be devised to obtain resting myocardial perfusion, myocardial perfusion after stress, and coronary anatomy. Hence, one diagnostic test will be able to detect the presence of coronary plaque as well as assess the functional significance of a stenosis.

Condition or Disease Intervention/Treatment Phase
  • Other: Adenosine Stress Dual-source CTP
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Myocardial Stress Perfusion Imaging With Dual Source CT
Study Start Date :
Apr 1, 2008
Actual Primary Completion Date :
Apr 1, 2010
Actual Study Completion Date :
Apr 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adenosine Stress Dual-source CTP

A multiphase adenosine Stress Dual-source stress perfusion computed tomography imaging test, as described above, will be performed in all patients.

Other: Adenosine Stress Dual-source CTP
Adenosine- continuous infusion at 140mcg/ kg/ min for 2.5 min; Iopamidol (IV contrast)- total dose of 150cc; Siemens SOMATOM Definition CT scanner (CT scan radiation) - effective radiation dose of approximately 13mSv (tube voltage 120kV, tube current 340mAs for one retrospectively gated cardiac CT with tube current modulation and two prospectively gated cardiac CTs on a Dual Source scanner) This is an observational trial, and all patients will undergo the Adenosine Stress Dual-source CTP procedure.
Other Names:
  • Adenosine
  • Iopamidol 370
  • Siemens SOMATOM Definition
  • Outcome Measures

    Primary Outcome Measures

    1. Per-Vessel Sensitivity of CTP in the Detection of Myocardial Perfusion Defects During Pharmacological Stress as Compared to Invasive Angiography. [18 months]

      The gold standard for abnormality by CTP is defined as a focal stenosis of >50% at quantitative analysis of invasive coronary angiography images, when performed.

    2. Per-Vessel Specificity of CTP in the Detection of Myocardial Perfusion Defects During Pharmacological Stress as Compared to Invasive Angiography. [18 months]

      The gold standard for abnormality by CTP is defined as stenosis of 50% or more at quantitative analysis of invasive coronary angiography images, when performed.

    Secondary Outcome Measures

    1. Per-Patient Correlation Between CTP and SPECT at Stress. [18 months]

      Pearson Correlation between research interpretation of CTP images and SPECT images, both performed during stress.

    2. Per-Patient Correlation Between CTP and SPECT at Rest. [18 months]

      Pearson Correlation performed on myocardial abnormalities on CTP and SPECT images, obtained at rest.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • A prior adenosine or exercise stress SPECT exam with high likelihood of being referred to the cardiac catheterization laboratory for invasive angiogram

    • Age > 40 years old

    • Able to comprehend and sign the consent form.

    Exclusion Criteria:
    • Acute coronary syndromes (unstable angina, non-ST elevation myocardial infarction, ST elevation myocardial infarction)

    • Unstable clinical conditions (i.e. hemodynamic instability, arrhythmias)

    • Premenopausal women who have a positive pregnancy test.

    • Serum Creatinine level ≥1.5 mg/dl as an indicator of renal insufficiency.

    • Known allergy to iodinated contrast agents

    • Atrial fibrillation

    • Asthma

    • Critical aortic stenosis

    • Systolic blood pressure < 90 mmHg

    • Advanced heart block

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Massachusetts General Hospital Boston Massachusetts United States 02114

    Sponsors and Collaborators

    • Massachusetts General Hospital
    • Astellas Pharma Inc

    Investigators

    • Principal Investigator: Brian B Ghoshhajra, MD, Massachusetts General Hospital
    • Study Director: Ricardo C Cury, MD, Massachusetts General Hospital, Baptist Hospital, Miami

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Brian Burns Ghoshhajra, Clinical Director, Cardiac CT and MRI, Department of Radiology, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT00853671
    Other Study ID Numbers:
    • DSCTSTRESS
    First Posted:
    Mar 2, 2009
    Last Update Posted:
    Dec 17, 2018
    Last Verified:
    Jun 1, 2018
    Keywords provided by Brian Burns Ghoshhajra, Clinical Director, Cardiac CT and MRI, Department of Radiology, Massachusetts General Hospital
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details Recruitment Period: 3/3/2008 - 7/1/2009
    Pre-assignment Detail
    Arm/Group Title Myocardial Stress CT Perfusion Imaging
    Arm/Group Description Patients who will undergo myocardial stress CT perfusion imaging. Adenosine- continuous infusion at 140mcg/ kg/ min for 2.5 min; Iopamidol (IV contrast)- total dose of 150cc; Siemens SOMATOM Definition CT scanner (CT scan radiation) - effective radiation dose of approximately 13mSv (tube voltage 120kV, tube current 340mAs for one retrospectively gated cardiac CT with tube current modulation and two prospectively gated cardiac CTs on a Dual Source scanner)
    Period Title: Overall Study
    STARTED 50
    COMPLETED 50
    NOT COMPLETED 0

    Baseline Characteristics

    Arm/Group Title Myocardial Stress CT Perfusion Imaging
    Arm/Group Description Patients who will undergo myocardial stress CT perfusion imaging.
    Overall Participants 50
    Age (Count of Participants)
    <=18 years
    0
    0%
    Between 18 and 65 years
    32
    64%
    >=65 years
    18
    36%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    62.3
    (10.4)
    Sex: Female, Male (Count of Participants)
    Female
    9
    18%
    Male
    41
    82%
    Region of Enrollment (participants) [Number]
    United States
    50
    100%

    Outcome Measures

    1. Primary Outcome
    Title Per-Vessel Sensitivity of CTP in the Detection of Myocardial Perfusion Defects During Pharmacological Stress as Compared to Invasive Angiography.
    Description The gold standard for abnormality by CTP is defined as a focal stenosis of >50% at quantitative analysis of invasive coronary angiography images, when performed.
    Time Frame 18 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Myocardial Stress CT Perfusion Imaging
    Arm/Group Description Patients who will undergo myocardial stress CT perfusion imaging.
    Measure Participants 50
    Number (95% Confidence Interval) [percentage of participants]
    79
    158%
    2. Secondary Outcome
    Title Per-Patient Correlation Between CTP and SPECT at Stress.
    Description Pearson Correlation between research interpretation of CTP images and SPECT images, both performed during stress.
    Time Frame 18 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Myocardial Stress CT Perfusion Imaging
    Arm/Group Description Patients who will undergo myocardial stress CT perfusion imaging.
    Measure Participants 50
    Number [correlation coefficient]
    0.60
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Myocardial Stress CT Perfusion Imaging
    Comments
    Type of Statistical Test Superiority or Other
    Comments
    Statistical Test of Hypothesis p-Value <0.0001
    Comments
    Method Pearson Correlation
    Comments
    3. Primary Outcome
    Title Per-Vessel Specificity of CTP in the Detection of Myocardial Perfusion Defects During Pharmacological Stress as Compared to Invasive Angiography.
    Description The gold standard for abnormality by CTP is defined as stenosis of 50% or more at quantitative analysis of invasive coronary angiography images, when performed.
    Time Frame 18 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Myocardial Stress CT Perfusion Imaging
    Arm/Group Description Patients who will undergo myocardial stress CT perfusion imaging.
    Measure Participants 50
    Number (95% Confidence Interval) [percentage of participants]
    80
    160%
    4. Secondary Outcome
    Title Per-Patient Correlation Between CTP and SPECT at Rest.
    Description Pearson Correlation performed on myocardial abnormalities on CTP and SPECT images, obtained at rest.
    Time Frame 18 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Myocardial Stress CT Perfusion Imaging
    Arm/Group Description Patients who will undergo myocardial stress CT perfusion imaging.
    Measure Participants 50
    Number [correlation coefficient]
    0.76
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Myocardial Stress CT Perfusion Imaging
    Comments Pearson Correlation
    Type of Statistical Test Superiority or Other
    Comments
    Statistical Test of Hypothesis p-Value <0.0001
    Comments
    Method Pearson Correlation
    Comments

    Adverse Events

    Time Frame 1 day
    Adverse Event Reporting Description To assure subject's safety, the study physician will monitor the safety of the subject. Heart rate and blood pressure will be measured immediately prior and 2 and 5 minutes after the administration of adenosine. ECG and heart rate will be continuously monitored during scanning. If adverse events occur the exam will immediately be stopped.
    Arm/Group Title Myocardial Stress CT Perfusion Imaging
    Arm/Group Description Patients who will undergo myocardial stress CT perfusion imaging.
    All Cause Mortality
    Myocardial Stress CT Perfusion Imaging
    Affected / at Risk (%) # Events
    Total / (NaN)
    Serious Adverse Events
    Myocardial Stress CT Perfusion Imaging
    Affected / at Risk (%) # Events
    Total 0/50 (0%)
    Other (Not Including Serious) Adverse Events
    Myocardial Stress CT Perfusion Imaging
    Affected / at Risk (%) # Events
    Total 0/50 (0%)

    Limitations/Caveats

    Single-Center Study, Referral Population

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.

    Results Point of Contact

    Name/Title Dr. Brian B. Ghoshhajra
    Organization Massachusetts General Hospital
    Phone 617-726-3745
    Email bghoshhajra@partners.org
    Responsible Party:
    Brian Burns Ghoshhajra, Clinical Director, Cardiac CT and MRI, Department of Radiology, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT00853671
    Other Study ID Numbers:
    • DSCTSTRESS
    First Posted:
    Mar 2, 2009
    Last Update Posted:
    Dec 17, 2018
    Last Verified:
    Jun 1, 2018